Expression, purification, and characterization of human and rat acetyl cfenzyme A carboxylase (ACC) isozymes

Acetyl coenzyme A (acetyl-CoA) carboxylase isozyme 1 (ACC1) and acetyl-CoA carboxylase isozyme 2 (ACC2) are critical for de novo fatty acid synthesis and for the regulation of β-oxidation. Emerging evidence indicates that one or both isozymes might be therapeutic targets for the treatment of obesity...

Full description

Saved in:
Bibliographic Details
Published inProtein expression and purification Vol. 51; no. 1; pp. 11 - 21
Main Authors Cheng, Dong, Chu, Ching-Hsuen, Chen, Luping, Feder, John N., Mintier, Gabe A., Wu, Yuli, Cook, Joseph W., Harpel, Mark R., Locke, Gregory A., An, Yongmi, Tamura, James K.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Acetyl coenzyme A (acetyl-CoA) carboxylase isozyme 1 (ACC1) and acetyl-CoA carboxylase isozyme 2 (ACC2) are critical for de novo fatty acid synthesis and for the regulation of β-oxidation. Emerging evidence indicates that one or both isozymes might be therapeutic targets for the treatment of obesity, type 2 diabetes, and dyslipidemia. One of the major obstacles in the field is the lack of readily-available source of recombinant human ACC enzymes to support systematic drug discovery efforts. Here, we describe an efficient and optimal protocol for expressing and isolating recombinant mammalian ACCs with high yield and purity. The resultant human ACC2, human ACC1, and rat ACC2 possess high specific activities, are properly biotinylated, and exhibit kinetic parameters very similar to the native ACC enzymes. We believe that the current study paves a road to a systematic approach for drug design revolving around the ACC inhibition mechanism.
ISSN:1046-5928
1096-0279
DOI:10.1016/j.pep.2006.06.005